Malaysia’s Ministry of Health is currently conducting an online survey to gauge the interests of Malaysians in getting the COVID-19 vaccine. Users are encouraged to participate via a Google web form and they do not collect any personal details.
The COVID-19 vaccine survey will ask about your age, gender, occupation, level of education and current medical conditions, if any. Next you’ll need to answer whether you agree to accept or reject the COVID-19 vaccination.
This is followed by a series of questions to determine your level of confidence in the vaccine when it comes to reducing the chance of getting infected, having possible complications, reducing risk of infecting others and if you have doubts about the source of the vaccine.
The survey also asks you if you’re willing to take the vaccine if is mandated by the government. It also asks if you would still agree to be vaccinated if you are required to pay for it. To provide your views about the COVID-19 vaccination, you can participate in the survey here.
As announced by Prime Minister Muhyiddin Yassin, Malaysia has finalised a deal to acquire 12.8 million doses of Pfizer Inc’s COVID-19 vaccine for 6.4 million people which is due to arrive in Q1 2021. The vaccines will be free for Malaysians with priority given to frontline health workers.
The government aims to secure enough vaccines to cover 70% of Malaysia’s population and it currently has signed purchase agreements to cover 20% with Pfizer and 10% with Covax vaccines. Health Minister Dr Adham Baba recently said that they are concluding a deal with AstraZeneca of the UK to acquire enough doses to cover 20% of the population. This will bring the total COVID-19 vaccination population coverage to 50%.
Before the COVID-19 vaccines can be administered to Malaysians, Health director-general Dr Noor Hisham Abdullah has said that it must first get Ministry of Health’s approval. He denies claims that being first in line for the vaccines were equivalent to being test subjects or ‘lab rats’. He emphasised that a great amount of research and evaluation is needed before approving the use of any vaccine.
[ SOURCE, IMAGE SOURCE ]